ArticleAmerican heart journal plus : cardiology research and practice2026
Incorporating of an enhanced radiation protection device into the treatment of ST elevation myocardial infarctions: A single center retrospective analysis.
Article in American heart journal plus : cardiology research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Study objective: To evaluate whether incorporation of the EggNest Complete enhanced radiation protection device (ERPD) affects door-to-balloon (D2B) time in treatment of patients presenting with ST-elevation myocardial infarction (STEMI). Design: Single-center retrospective observational study. Setting: Catheterization laboratories in a tertiary care hospital. Participants: 133 consecutive patients presenting with STEMI (71 in the ERPD group, 62 in the standard shielding) group from July 1, 2024 until December 31, 2025. Interventions: Evaluation of D2B time components in rooms with ERPD vs standard shielding. Main outcome measure: D2B time (total time and time-based components). Results: There was no statistically significant difference in overall D2B times between groups (48.0 vs 52.0 min; Conclusion: Use of the EggNest Complete ERPD does not delay STEMI reperfusion. These findings support a paradigm shift from operator-dependent shielding to integrated, system-level radiation protection, demonstrating that improvements in occupational safety for cath lab workers can be achieved without tradeoffs in the timeliness of life-saving reperfusion therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.